Annual EBIT
-$45.89 M
+$32.65 M+41.57%
31 December 2023
Summary:
Akebia Therapeutics annual earnings before interest & taxes is currently -$45.89 million, with the most recent change of +$32.65 million (+41.57%) on 31 December 2023. During the last 3 years, it has risen by +$331.93 million (+87.85%). AKBA annual EBIT is now -438.46% below its all-time high of -$4.05 million.AKBA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$13.38 M
-$6.95 M-107.96%
30 September 2024
Summary:
Akebia Therapeutics quarterly earnings before interest & taxes is currently -$13.38 million, with the most recent change of -$6.95 million (-107.96%) on 30 September 2024. Over the past year, it has dropped by -$299.00 thousand (-2.29%). AKBA quarterly EBIT is now -138.79% below its all-time high of $34.49 million, reached on 30 June 2022.AKBA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$33.27 M
-$299.00 K-0.91%
30 September 2024
Summary:
Akebia Therapeutics TTM earnings before interest & taxes is currently -$33.27 million, with the most recent change of -$299.00 thousand (-0.91%) on 30 September 2024. Over the past year, it has increased by +$19.09 million (+36.47%). AKBA TTM EBIT is now -1191.03% below its all-time high of -$2.58 million, reached on 31 March 2013.AKBA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.6% | -2.3% | +36.5% |
| 3 y3 years | +87.8% | +75.4% | +88.3% |
| 5 y5 years | +74.2% | +76.1% | +88.2% |
AKBA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +87.8% | -138.8% | +80.1% | -0.9% | +88.3% |
| 5 y | 5 years | at high | +87.8% | -138.8% | +92.3% | -0.9% | +91.3% |
| alltime | all time | -438.5% | +87.8% | -138.8% | +92.3% | -1191.0% | +91.3% |
Akebia Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.38 M(+108.0%) | -$33.27 M(+0.9%) |
| June 2024 | - | -$6.43 M(-58.5%) | -$32.97 M(-8.6%) |
| Mar 2024 | - | -$15.49 M(-862.2%) | -$36.06 M(-21.4%) |
| Dec 2023 | -$45.89 M(-41.6%) | $2.03 M(-115.5%) | -$45.89 M(-12.4%) |
| Sept 2023 | - | -$13.08 M(+37.2%) | -$52.36 M(-41.4%) |
| June 2023 | - | -$9.53 M(-62.4%) | -$89.42 M(+96.9%) |
| Mar 2023 | - | -$25.32 M(+470.8%) | -$45.41 M(-41.4%) |
| Dec 2022 | -$78.54 M(-70.3%) | -$4.43 M(-91.2%) | -$77.45 M(-44.8%) |
| Sept 2022 | - | -$50.14 M(-245.4%) | -$140.21 M(-3.0%) |
| June 2022 | - | $34.49 M(-160.1%) | -$144.53 M(-43.8%) |
| Mar 2022 | - | -$57.36 M(-14.6%) | -$257.09 M(-2.8%) |
| Dec 2021 | -$264.50 M(-30.0%) | -$67.19 M(+23.4%) | -$264.50 M(-7.3%) |
| Sept 2021 | - | -$54.46 M(-30.2%) | -$285.23 M(-1.1%) |
| June 2021 | - | -$78.08 M(+20.5%) | -$288.46 M(-24.8%) |
| Mar 2021 | - | -$64.78 M(-26.3%) | -$383.83 M(+1.6%) |
| Dec 2020 | -$377.83 M(+32.0%) | -$87.92 M(+52.4%) | -$377.83 M(-1.8%) |
| Sept 2020 | - | -$57.69 M(-66.7%) | -$384.79 M(+0.5%) |
| June 2020 | - | -$173.44 M(+195.1%) | -$383.01 M(+42.3%) |
| Mar 2020 | - | -$58.77 M(-38.1%) | -$269.09 M(-6.0%) |
| Dec 2019 | -$286.29 M(+60.7%) | -$94.89 M(+69.7%) | -$286.29 M(+1.7%) |
| Sept 2019 | - | -$55.91 M(-6.1%) | -$281.56 M(+11.1%) |
| June 2019 | - | -$59.52 M(-21.6%) | -$253.49 M(+10.4%) |
| Mar 2019 | - | -$75.97 M(-15.7%) | -$229.63 M(+28.9%) |
| Dec 2018 | -$178.16 M | -$90.16 M(+223.8%) | -$178.16 M(+142.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$27.84 M(-21.9%) | -$73.39 M(+5.3%) |
| June 2018 | - | -$35.66 M(+45.6%) | -$69.73 M(+24.1%) |
| Mar 2018 | - | -$24.50 M(-267.7%) | -$56.20 M(-26.7%) |
| Dec 2017 | -$76.67 M(-43.8%) | $14.61 M(-160.4%) | -$76.67 M(-40.7%) |
| Sept 2017 | - | -$24.18 M(+9.2%) | -$129.33 M(-8.5%) |
| June 2017 | - | -$22.14 M(-50.8%) | -$141.33 M(-9.0%) |
| Mar 2017 | - | -$44.97 M(+18.2%) | -$155.39 M(+13.9%) |
| Dec 2016 | -$136.46 M(+121.8%) | -$38.04 M(+5.1%) | -$136.46 M(+15.2%) |
| Sept 2016 | - | -$36.18 M(-0.0%) | -$118.47 M(+16.2%) |
| June 2016 | - | -$36.19 M(+38.9%) | -$101.96 M(+33.0%) |
| Mar 2016 | - | -$26.05 M(+29.9%) | -$76.66 M(+24.6%) |
| Dec 2015 | -$61.51 M(+62.1%) | -$20.05 M(+1.9%) | -$61.51 M(+18.1%) |
| Sept 2015 | - | -$19.68 M(+80.7%) | -$52.07 M(+24.0%) |
| June 2015 | - | -$10.89 M(-0.1%) | -$41.98 M(+7.8%) |
| Mar 2015 | - | -$10.90 M(+2.7%) | -$38.93 M(+2.6%) |
| Dec 2014 | -$37.94 M(+138.1%) | -$10.61 M(+10.7%) | -$37.94 M(+13.1%) |
| Sept 2014 | - | -$9.58 M(+22.2%) | -$33.53 M(+19.8%) |
| June 2014 | - | -$7.84 M(-20.9%) | -$27.98 M(+20.3%) |
| Mar 2014 | - | -$9.91 M(+59.8%) | -$23.26 M(+46.0%) |
| Dec 2013 | -$15.93 M(+86.9%) | -$6.20 M(+53.7%) | -$15.93 M(+63.7%) |
| Sept 2013 | - | -$4.03 M(+29.3%) | -$9.73 M(+70.8%) |
| June 2013 | - | -$3.12 M(+21.1%) | -$5.70 M(+121.1%) |
| Mar 2013 | - | -$2.58 M | -$2.58 M |
| Dec 2012 | -$8.52 M | - | - |
FAQ
- What is Akebia Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Akebia Therapeutics?
- What is Akebia Therapeutics annual EBIT year-on-year change?
- What is Akebia Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly EBIT year-on-year change?
- What is Akebia Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Akebia Therapeutics?
- What is Akebia Therapeutics TTM EBIT year-on-year change?
What is Akebia Therapeutics annual earnings before interest & taxes?
The current annual EBIT of AKBA is -$45.89 M
What is the all time high annual EBIT for Akebia Therapeutics?
Akebia Therapeutics all-time high annual earnings before interest & taxes is -$4.05 M
What is Akebia Therapeutics annual EBIT year-on-year change?
Over the past year, AKBA annual earnings before interest & taxes has changed by +$32.65 M (+41.57%)
What is Akebia Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of AKBA is -$13.38 M
What is the all time high quarterly EBIT for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly earnings before interest & taxes is $34.49 M
What is Akebia Therapeutics quarterly EBIT year-on-year change?
Over the past year, AKBA quarterly earnings before interest & taxes has changed by -$299.00 K (-2.29%)
What is Akebia Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of AKBA is -$33.27 M
What is the all time high TTM EBIT for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM earnings before interest & taxes is -$2.58 M
What is Akebia Therapeutics TTM EBIT year-on-year change?
Over the past year, AKBA TTM earnings before interest & taxes has changed by +$19.09 M (+36.47%)